These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2217771)

  • 1. Persistent and recurrent hyperparathyroidism: assessment with gadopentetate dimeglumine-enhanced MR imaging.
    Seelos KC; DeMarco R; Clark OH; Higgins CB
    Radiology; 1990 Nov; 177(2):373-8. PubMed ID: 2217771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of the normal and abnormal clivus.
    Kimura F; Kim KS; Friedman H; Russell EJ; Breit R
    AJR Am J Roentgenol; 1990 Dec; 155(6):1285-91. PubMed ID: 2122682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
    Fernandez MP; Bernardino ME; Neylan JF; Olson RA
    AJR Am J Roentgenol; 1991 Jun; 156(6):1171-6. PubMed ID: 2028861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast.
    Elster AD; King JC; Mathews VP; Hamilton CA
    Radiology; 1994 Feb; 190(2):541-6. PubMed ID: 8284413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
    Hricak H; Finck S; Honda G; Göranson H
    AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of magnetic resonance imaging in hyperparathyroidism.
    Higgins CB
    Radiol Clin North Am; 1993 Sep; 31(5):1017-28. PubMed ID: 8362052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
    Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
    Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
    AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The signal behavior of parathyroid adenomas in MRT--the contrast ratio of the thyroid and fatty tissue].
    Peiss J; Füzesi L; Bohndorf K; Gladziwa U; Günther RW
    Rofo; 1992 Feb; 156(2):130-4. PubMed ID: 1739770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
    Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
    Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
    Nakahara H; Noguchi S; Murakami N; Tamura S; Jinnouchi S; Kodama T; Adjei ON; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
    Radiology; 1997 Mar; 202(3):765-72. PubMed ID: 9051032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid knee: role of gadopentetate-enhanced MR imaging.
    Kursunoglu-Brahme S; Riccio T; Weisman MH; Resnick D; Zvaifler N; Sanders ME; Fix C
    Radiology; 1990 Sep; 176(3):831-5. PubMed ID: 2389044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.